PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells

PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells

Shijie Xu,1,* Fangbo Cui,2,3,* Dafu Huang,4,* Dinghu Zhang,5 Anqing Zhu,6 Xia Sun,6 Yiming Cao,7 Sheng Ding,7 Yao Wang,7 Eryun Gao,3 Fenglin Zhang3 1Center for Public Health Research, Medical School, Nanjing University, Nanjing, China; 2Department of Oncology, Wannan Medical College, Wuhu, Anhui, C...

Full description

Bibliographic Details
Main Authors: Xu S, Cui F, Huang D, Zhang D, Zhu A, Sun X, Cao YM, Ding S, Wang Y, Gao E, Zhang F
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:International Journal of Nanomedicine
Subjects:
DOC
Gastric carcinoma
PD-L1 monoclonal antibody
Nanomedicine
Drug delivery
Online Access:https://www.dovepress.com/pd-l1-monoclonal-antibody-conjugated-nanoparticles-enhance-drug-delive-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/pd-l1-monoclonal-antibody-conjugated-nanoparticles-enhance-drug-delive-peer-reviewed-article-IJN

Similar Items